Nigel Deeks

971 total citations
11 papers, 608 citations indexed

About

Nigel Deeks is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Nigel Deeks has authored 11 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Nigel Deeks's work include Neurotransmitter Receptor Influence on Behavior (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Nigel Deeks is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (4 papers), Drug Transport and Resistance Mechanisms (2 papers) and Sphingolipid Metabolism and Signaling (2 papers). Nigel Deeks collaborates with scholars based in United Kingdom, United States and Netherlands. Nigel Deeks's co-authors include Philip D. Jeffrey, Tania O. Stean, Gary Price, David R. Thomas, Graham J. Riley, Jim J. Hagan, Derek N. Middlemiss, Neil Upton, Steven M. Bromidge and Andrew D. Medhurst and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Journal of Pharmaceutical Sciences.

In The Last Decade

Nigel Deeks

11 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nigel Deeks United Kingdom	8	350	301	96	63	58	11	608
Kenneth M. Johnson United States	14	653 1.9×	414 1.4×	122 1.3×	77 1.2×	22 0.4×	16	931
Lucinda J. Steward United Kingdom	17	536 1.5×	502 1.7×	127 1.3×	25 0.4×	44 0.8×	25	903
Jens Nagel Germany	18	490 1.4×	328 1.1×	110 1.1×	32 0.5×	20 0.3×	33	805
Peter Baumann Switzerland	13	499 1.4×	368 1.2×	76 0.8×	47 0.7×	74 1.3×	21	729
Michael A. Ackley United States	13	401 1.1×	287 1.0×	54 0.6×	45 0.7×	40 0.7×	22	859
Michael C. Hanna United States	9	424 1.2×	528 1.8×	53 0.6×	34 0.5×	19 0.3×	10	793
Mary Cohen-Williams United States	17	445 1.3×	441 1.5×	87 0.9×	33 0.5×	79 1.4×	28	892
Anna Siniscalchi Italy	16	480 1.4×	393 1.3×	97 1.0×	40 0.6×	24 0.4×	38	709
Dominique Quarteronet France	8	426 1.2×	306 1.0×	49 0.5×	61 1.0×	31 0.5×	10	563
Kim Y. Avenell United Kingdom	7	519 1.5×	357 1.2×	70 0.7×	13 0.2×	62 1.1×	8	686

Countries citing papers authored by Nigel Deeks

Since Specialization

Citations

This map shows the geographic impact of Nigel Deeks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nigel Deeks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nigel Deeks more than expected).

Fields of papers citing papers by Nigel Deeks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nigel Deeks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nigel Deeks. The network helps show where Nigel Deeks may publish in the future.

Co-authorship network of co-authors of Nigel Deeks

This figure shows the co-authorship network connecting the top 25 collaborators of Nigel Deeks. A scholar is included among the top collaborators of Nigel Deeks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nigel Deeks. Nigel Deeks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Hirst, David J., Martín Brandt, Gordon Bruton, et al.. (2020). Structure-based optimisation of orally active & reversible MetAP-2 inhibitors maintaining a tight ‘molecular budget’. Bioorganic & Medicinal Chemistry Letters. 30(21). 127533–127533. 6 indexed citations

Taylor, S., Emmanuel H. Demont, James R. Gray, et al.. (2015). Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P ₁ Agonists. Journal of Medicinal Chemistry. 58(20). 8236–8256. 13 indexed citations

Taylor, S., James R. Gray, Robert Willis, et al.. (2012). The utility of pharmacokinetic–pharmacodynamic modeling in the discovery and optimization of selective S1P₁agonists. Xenobiotica. 42(7). 671–686. 4 indexed citations

Snoek, Susanne A., Marleen I. Verstege, Esmerij P. van der Zanden, et al.. (2010). Selective α7 nicotinic acetylcholine receptor agonists worsen disease in experimental colitis. British Journal of Pharmacology. 160(2). 322–333. 70 indexed citations

Briggs, Michael A., Tsu Tshen Chuang, Nigel Deeks, et al.. (2008). Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(20). 5698–5700. 15 indexed citations

Cutler, Leanne, et al.. (2006). Development of a P-Glycoprotein Knockout Model in Rodents to Define Species Differences in its Functional Effect at the Blood–brain Barrier. Journal of Pharmaceutical Sciences. 95(9). 1944–1953. 39 indexed citations

Thomas, David R., Sergio Melotto, Andrew D. Gribble, et al.. (2003). SB‐656104‐A, a novel selective 5‐HT₇ receptor antagonist, modulates REM sleep in rats. British Journal of Pharmacology. 139(4). 705–714. 101 indexed citations

Stean, Tania O., Warren D. Hirst, David R. Thomas, et al.. (2002). Pharmacological profile of SB-357134: A potent, selective, brain penetrant, and orally active 5-HT6 receptor antagonist. Pharmacology Biochemistry and Behavior. 71(4). 645–654. 53 indexed citations

Austin, Nigel, Leanne Cutler, Nigel Deeks, et al.. (2001). Pharmacokinetics of the novel, high-affinity and selective dopamine D3 receptor antagonist SB-277011 in rat, dog and monkey:in vitro/in vivocorrelation and the role of aldehyde oxidase. Xenobiotica. 31(8-9). 677–686. 52 indexed citations

10.

Hagan, Jim J., Gary Price, Philip D. Jeffrey, et al.. (2000). Characterization of SB‐269970‐A, a selective 5‐HT₇ receptor antagonist. British Journal of Pharmacology. 130(3). 539–548. 254 indexed citations

11.

Woldemariam, Tibebe Z., P. Alex Linley, Anthony F. Fell, et al.. (1990). Short papers in pharmaceutical analysis. Analytical Proceedings. 27(7). 176–176. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact